Centrus Energy (LEU) Stock Valuation After Gulf Tensions And Energy Sector Volatility

Centrus Energy

Centrus Energy

LEU

0.00

Centrus Energy stock reacts to rising Gulf tensions

Centrus Energy (LEU) stock came under pressure after a reported 5.2% drop, as investors reacted to a US helicopter incident near Oman linked to Iran and renewed concerns around Gulf infrastructure risks.

Beyond the latest move, Centrus Energy’s share price has been under pressure in recent months, with a 30 day share price return of down 15.5% and a 90 day share price return of down 22.5%. The year to date share price return is down 40.3%, while its 5 year total shareholder return is roughly 6x. This suggests recent momentum has faded even though longer term holders have still seen very strong overall gains.

If you are following the nuclear fuel story and want to see what else is moving, it could be worth scanning 88 nuclear energy infrastructure stocks

With Centrus Energy now down sharply over the past quarter yet still carrying a roughly 5x total return over five years, should you see today’s valuation as a reset that opens a window, or as a sign that the market already expects plenty of growth?

Most Popular Narrative: 73.3% Undervalued

Against a last close of $162.58, the most followed narrative on Centrus Energy puts fair value at $609.90, implying a deep valuation gap that hinges on its unique role in US nuclear fuel.

Centrus Energy is one of those rare companies whose importance becomes clearer the deeper you look into the machinery of U.S. law, national security, and nuclear policy. In a sector defined by scarcity, Centrus isn’t just another uranium name, it is the only U.S. company legally authorized to enrich uranium for the federal government, a distinction rooted directly in federal statute. Under 10 U.S.C. § 2538a, the U.S. government is prohibited from purchasing enriched uranium for defense purposes from any entity that is not a U.S.-owned, U.S.-operated, and NRC-licensed enricher. That legal filter leaves exactly one company standing, Centrus. And that is before you even get to the fact that Centrus is also the only firm with an NRC license to produce HALEU, the fuel required for nearly every advanced reactor design the U.S. is trying to deploy.

This narrative, written by RetiredbutWorking, leans heavily on projected cash flows from enrichment and HALEU demand, then discounts them at a 7.108% rate to support that higher fair value. Curious which revenue growth and margin assumptions have to hold to bridge the gap between $162.58 and $609.90? The full narrative spells out the earnings profile and future valuation multiple that would need to materialise for that price to make sense.

Result: Fair Value of $609.90 (UNDERVALUED)

However, you also need to weigh risks, including potential changes in US nuclear policy or slower than expected HALEU adoption that could challenge this bullish narrative.

Another View: Earnings Multiple Sends A Different Signal

While the community narrative leans on future cash flows and a $609.90 fair value, the current earnings multiple points the other way. At a P/E of 52.8x versus 13.8x for the US Oil and Gas industry, 11.5x for peers, and a 9.6x fair ratio, the stock screens as expensive and leaves less room for error if growth disappoints.

To see how this earnings based view fits with the wider valuation picture, including the fair ratio the market could move toward over time, See what the numbers say about this price — find out in our valuation breakdown.

NYSE:LEU P/E Ratio as at Jun 2026
NYSE:LEU P/E Ratio as at Jun 2026

Next Steps

With sentiment split between strong long term gains and recent share price pressure, it helps to move quickly and test the thesis against the numbers yourself. To weigh both sides of the story before you decide what comes next, start with the 1 key reward and 5 important warning signs.

Looking for more investment ideas?

If you stop here, you could miss stocks that better fit your goals, so keep building your watchlist and pressure test every idea before putting money to work.

  • Spot potential upside early by scanning 44 high quality undervalued stocks that pair quality fundamentals with prices that sit below their assessed worth.
  • Build a steadier income stream by reviewing 8 dividend fortresses that combine higher yields with an emphasis on resilience.
  • Protect your downside by checking 70 resilient stocks with low risk scores focused on companies with more stable profiles and lower flagged risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.